Global Health and Population Project on Access to Care for Cardiometabolic Diseases (HPACC)

The Global Health and Population Project on Access to Care for Cardiometabolic Diseases (HPACC) is an international consortium aimed at addressing cardiometabolic disease concerns globally. It collects and harmonizes data, especially from low- and middle-income countries, aiming to fill research gaps and become a leading center for data sharing and analysis. 

Global Health and Population Project on Access to Care for Cardiometabolic Diseases (HPACC) is an international research consortium and was established to meet the clear need for answers to key health policy and clinical questions relating to cardiometabolic diseases globally. We search, obtain and harmonize nationally representative survey data on cardiometabolic diseases with a focus on low- and middle-income countries (LMICs) to close existing research gaps. Our goal is to become a global center of excellence for data sharing and analysis related to cardiometabolic diseases.

HPACC currently consists of nationally representative, population-based surveys from 76 countries across 6 world regions. HPACC has individual-level data of over 1.2 million adults. Surveys were conducted from 2005 to 2019 and most surveys are WHO STEPS or DHS surveys. More information can be found at https://www.hpaccproject.org/.
 
HPACC is a collaboration of more than 80 physicians, economists, and public health researchers from more than 30 countries. The leadership team comes from Harvard University, Stanford University, the University of Göttingen, Heidelberg University, the University of Birmingham, and the University of Edinburgh. 

HPACC is proudly supported by the Harvard McLennan Family Fund, Alexander von Humboldt Foundation, Michigan Center for Diabetes Translational Research, and institutional funds from the Heidelberg Universities and Universities of Göttingen.